-
David Kelly, Research Scientist, celebrates 10 years with PBC Biomed.
Congratulations to one of PBC Biomed‘s longest standing team members David Kelly, on celebrating 10 years with the company last week. Always ready to offer his insight and support, David has become a critical part of the R&D team since he joined the company a decade ago. Pictured is PBC Biomed’s CSO Gerard Insley, presenting David with his…
-
PBC Biomed Team in Memphis, February 2024.
The PBC Biomed team are in Memphis this week, introducing our new Business Development manager David Sharp to our local network! If you are in the Downtown Memphis area and would like to say hi to David, Brittney, Elaine or Pierse, please feel free to stop by our office at Epicenter Memphis. The team will be there when they’re not sampling the local cuisine! #memphis#USoffice#newhire#businessdevelopment#pbcbiomed
-
DTIF-funded project, OsStic® technology awarded #BreakthroughDevice designation by the FDA.
Shannon, Ireland, February 12th 2024: Irish medical device company Biomimetic Innovations Ltd, an affiliate of PBC Biomed, announced ‘Breakthrough Device’ designation from the Food and Drug Administration FDA in January, for the development of a groundbreaking new bio-adhesive bone void filler technology called OsStic®. PBC Biomed leads a consortium for this development project, which is…
-
New Hire: David Sharp, US Business Development Lead.
A very warm welcome to the newest member of the PBC Biomed team David Sharp, who has just joined as our US Business Development lead. David spent some time in our Irish headquarters this week to meet the extended team, however he will be based out of our US office at Epicenter Memphis. During his 25+ years working within…
-
ESTROT 2024
PBC Biomed will be exhibiting at the 8th annual ESTROT Congress in Helsinki, Finland from 10-12th June. This year, the programme focuses on: Event information and registration is available here: https://www.estrot.org/eighth-estrot-congress-24.php
-
OTA Annual Congress 2024
Part 3 of the PBC Biomed ‘Provisional Fixation’ Education Programme is scheduled to air at the OTA annual conference in Montreal, Canada. Our global panel of surgeon advisors will offer further insight on the future of ‘Provisional Fixation’ and the role of our new #breakthroughdevice OsStic® in changing the outlook on patient treatment. The conference…
-
OMTEC 2024
Join us in Chicago for the 2024 OMTEC event, which will provide an opportunity to connect with some of our key R&D and commercial team members. The theme of this year’s event is ‘Educate. Connect. Empower.’ More information on the event is available here: https://omtecexpo.com/
-
ODT Forum 2024
Our US-based PBC Biomed team members will attend the ODT meeting in Memphis this year, a little over a year on from opening the first US office location. This is the first time PBC Biomed will be exhibiting at the event – we look forward to another opportunity to rub shoulders with the ever-evolving Memphis…
-
PBC Biomed had the pleasure of hosting our Clinical Advisory Board at the Medical Education & Research Institute in Memphis last week, for a development lab focused on OsStic®.
The feedback and insights shared by this group are critical in supporting our development and educational objectives for OsStic®, which was recently awarded #BreakthroughDevice Designation. The group also looked at our other innovation programmes, including a #disruptive technology focused on nerve repair, as well as multiple new hardware concepts. Our R&D team have been working closely with our surgeon…
-
FDA grants global Medical Device company Biomimetic Innovations ‘Breakthrough Device’ designation for OsStic® Synthetic Injectable Structural Bio-Adhesive Bone Void Filler.Â
Shannon, Ireland, 19th January, 2024: Biomimetic Innovations Ltd today announced that OsStic® has been granted ‘Breakthrough Device’ designation by the FDA. The proposed indication statement for this novel new technology is; ” OsStic®Synthetic Injectable Bone Void Filler is a structural, mechanically enhanced bioadhesive for reduction, provisional fixation, or void filling of peri-articular fractures or defects…
Search News Items
Categories
- Awards (5)
- Biomaterials (11)
- Biovet (8)
- Bone Adhesive (13)
- Bone Disease Solution (3)
- Bone Healing (9)
- Certification (1)
- Client (2)
- Collaboration (18)
- Conferences (15)
- Contract Manufacturing (2)
- Day One Trauma Charity (1)
- Development (11)
- Events (48)
- Government Funding (2)
- Lectures (6)
- Medical Devices (8)
- Medical Implants (6)
- Memphis Office (6)
- New Hire (8)
- On TV/Radio (2)
- Press Release (8)
- Publications (7)
- ReFeelNerveRepairSolution (3)
- Regenerative Medicine (10)
- Relationship-building (13)
- Research (11)
- Sports & Social (2)
- Student Placements (2)
- Uncategorized (6)
- Upcoming Events (3)
- US Office (3)